Close Menu
News JournosNews Journos
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
Editors Picks

U.S. Report: Iran 3 to 8 Months from Nuclear Weapon, No Indication of Intent to Arm

June 24, 2025

Trump Embraces Monarchical Language in Recent Actions

February 20, 2025

Bruce Springsteen Addresses Trump Feud During Autograph Signing

May 18, 2025

Markets Rebuild Confidence in Trump Amid Ongoing Trade Deal Progress

May 13, 2025

Bipartisan Governors Urge Trump to Allow States Greater Authority on Immigration Decisions

February 22, 2025
Facebook X (Twitter) Instagram
Latest Headlines:
  • Employee Compensation Issues: Salary and Benefits Under Scrutiny
  • Key Insights from June 29, 2025, ‘Face the Nation’ Episode
  • WHO Study Reveals Teenage Girls as the Loneliest Population Worldwide
  • Audio Reveals Ambush on Idaho Firefighters Responding to Blaze
  • Supreme Court Restricts Judges’ Authority on Birthright Citizenship Order
  • Legendary Triple Crown Trainer D. Wayne Lukas Passes Away at 89
  • UK Punk-Rap Duo Criticized for “Death to the IDF” Chants at Festival
  • New Superman Film Emphasizes Grounded Approach, Says Director James Gunn and Star David Corenswet
  • Canada Repeals Digital Services Tax Following U.S. Trade Negotiation Breakdown
  • Russia Executes Largest Airstrike of the War, Ukraine Reports
  • Justice Department Commits to Address Surge in Attacks on Religious Facilities
  • Idaho Firefighters Targeted in Deadly Sniper Ambush; Two Fatalities Reported
  • USMNT Advances to Gold Cup Semifinals with Key Saves from Freese Against Costa Rica
  • Iran’s Nuclear Capabilities Reportedly Suffer Severe Damage, Says Watchdog Director
  • AKP Deputy Advises Provincial Chairman: “If You Fear, Sit at Home with Your Wife”
  • Sen. Mark Warner Discusses Tech Regulation and National Security on Major Broadcast.
  • Shiite Leader’s Fatwa Declares Trump and Netanyahu ‘Warlords’ Amid Rising Tensions
  • States Prepare for Potential Trade War Amid Varying Levels of Concern
  • Thousands of Tasmanian Tiger Sightings Reported in Australia Amid Extinction Search
  • Rep. McCaul Discusses Key Issues on National Television
Facebook X (Twitter) Instagram
News JournosNews Journos
Subscribe
Monday, June 30
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
News JournosNews Journos
You are here: News Journos » Top Stories » FDA Chief Counsel Resigns Just Two Days After Appointment
FDA Chief Counsel Resigns Just Two Days After Appointment

FDA Chief Counsel Resigns Just Two Days After Appointment

News EditorBy News EditorMarch 13, 2025 Top Stories 5 Mins Read

In a surprising development, the new Chief Counsel of the Food and Drug Administration (FDA), Hilary K. Perkins, has resigned just two days after her appointment. This abrupt exit comes amid a broader reorganization effort by the Department of Health and Human Services (HHS) led by Secretary Robert F. Kennedy Jr.. Perkins, who previously held a significant role within the Biden administration’s Department of Justice, had been viewed as a controversial yet key figure in the HHS’s attempt to revitalize the agency’s focus on public health and science.

Article Subheadings
1) Perkins’ Background and Role
2) The Context of Her Appointment
3) Reasons Behind Resignation
4) Implications for FDA and HHS
5) Future Directions for the FDA

Perkins’ Background and Role

Hilary K. Perkins comes with a notable background, having served as an assistant director in the Department of Justice’s consumer protection unit. Her extensive experience in regulatory affairs made her a fitting candidate for the Chief Counsel position at the FDA. However, her role was not just limited to legal advice; Perkins was expected to advocate for policies that prioritize public health over corporate interests, a crucial stance in the wake of growing distrust in food and drug safety. Her previous work defending access to abortion pills during critical legal battles positioned her as a figure of both strong support and fierce opposition among varying political factions.

The Context of Her Appointment

Perkins’ appointment was announced as part of a reorganization strategy by HHS, which aims to recalibrate its focus toward evidence-based medicine and public health concerns. Secretary Robert F. Kennedy Jr. expressed confidence that the recent restructuring would lead to higher-quality personnel being brought into the organization, stating, “We’ve been able to recruit higher quality personnel to HHS than at any time in its history.” This optimistic assessment underscored the aspirational goals of the HHS, which aims to transform the agency’s reputation and operational effectiveness.

Reasons Behind Resignation

Perkins’ resignation has raised eyebrows and questions within the circles she had just recently entered. Reports indicated discontent among HHS officials regarding her selection; it was alleged they were overruled in favor of her appointment by White House officials. The circumstances surrounding her departure hints at a possible internal friction and a disconnect between the ambitions of the HHS leadership and the broader political dynamics in play. Perkins stepped down amid criticism and scrutiny that may have compounded into a hostile working environment, exacerbating the difficulties associated with her new responsibilities.

Implications for FDA and HHS

The rapid succession of events is significant for the FDA and HHS’s strategic objectives. With Perkins no longer at the helm, the agency must seek another legal leader who can navigate both the regulatory landscapes and the political pressures inherent in FDA’s core functions. Observers have speculated that this unanticipated change could hinder the HHS’s capacity to effectively implement the reorganization plan aimed at prioritizing public health. Moreover, the departure of such a visible figure so soon may trigger further instability and uncertainty within the agency’s leadership, potentially impacting critical policy decisions that affect public health initiatives and regulatory practices.

Future Directions for the FDA

As the FDA moves forward from this leadership change, the organization will likely prioritize finding a new Chief Counsel who is not only well-versed in legal complexities but also aligned with the mission of returning to “gold-standard science and evidence-based medicine.” This search for new leadership is crucial as the FDA looks to maintain its credibility and restore public trust in its regulatory processes. Stakeholders within the health sector are observing closely how HHS responds to the sudden vacancy and what steps will be taken to continue prioritizing transparency, effectiveness, and a health-centric agenda in the face of ongoing public health challenges.

No. Key Points
1 Hilary K. Perkins has resigned as Chief Counsel of the FDA just two days after her appointment.
2 Her resignation comes amid reported tensions within the HHS regarding her appointment.
3 Perkins was previously involved in the defense of reproductive rights during her time at the DOJ.
4 The FDA’s search for a new Chief Counsel will be critical for upcoming public health initiatives.
5 The overall effectiveness of the HHS’s reorganization may be compromised by this leadership shakeup.

Summary

The resignation of Hilary K. Perkins from her position as Chief Counsel of the FDA has taken many by surprise and raises questions about the internal dynamics at play within the HHS. Her departure, just days after her appointment, highlights potential conflicts and challenges as the agency aims to refocus on evidence-based policies. As the FDA navigates this new chapter, the implications of such leadership changes will be watched closely, especially regarding how it will shape future policies and instill public confidence in the FDA’s regulatory framework.

Frequently Asked Questions

Question: Who is Hilary K. Perkins?

Hilary K. Perkins is the former Chief Counsel of the FDA who has recently resigned from her position. She previously served as an assistant director in the Department of Justice, focusing on consumer protection.

Question: Why did Perkins resign from the FDA?

Perkins resigned just two days after her appointment, amidst reports of dissatisfaction among HHS officials regarding her selection, which was made by White House officials against the organization’s preferences.

Question: What are the implications of her resignation for the FDA?

Her resignation could hinder the FDA’s efforts to implement a reorganization plan that aims to prioritize public health and evidence-based medicine, affecting the agency’s credibility and operational effectiveness going forward.

Appointment Breaking News Chief Counsel Critical Events days Economic Trends Exclusive Reports FDA Global Headlines Hot Topics In-Depth Stories Investigative News Latest Headlines Live Updates Local Highlights Major Announcements National Updates Opinion & Analysis Political Developments Resigns Social Issues Special Coverage Top Stories Trending Topics Viral News
Share. Facebook Twitter Pinterest LinkedIn Email Reddit WhatsApp Copy Link Bluesky
News Editor
  • Website

As the News Editor at News Journos, I am dedicated to curating and delivering the latest and most impactful stories across business, finance, politics, technology, and global affairs. With a commitment to journalistic integrity, we provide breaking news, in-depth analysis, and expert insights to keep our readers informed in an ever-changing world. News Journos is your go-to independent news source, ensuring fast, accurate, and reliable reporting on the topics that matter most.

Keep Reading

Top Stories

Audio Reveals Ambush on Idaho Firefighters Responding to Blaze

5 Mins Read
Top Stories

Legendary Triple Crown Trainer D. Wayne Lukas Passes Away at 89

6 Mins Read
Top Stories

USMNT Advances to Gold Cup Semifinals with Key Saves from Freese Against Costa Rica

6 Mins Read
Top Stories

Iran’s Nuclear Capabilities Reportedly Suffer Severe Damage, Says Watchdog Director

5 Mins Read
Top Stories

Thousands of Tasmanian Tiger Sightings Reported in Australia Amid Extinction Search

7 Mins Read
Top Stories

Rockies’ Warren Schaeffer Ejected in Win Against Brewers

5 Mins Read
Mr Serdar Avatar

Serdar Imren

News Director

Facebook Twitter Instagram
Journalism Under Siege
Editors Picks

House Supports Trump Tariffs in Key Foreign Manufacturing Bill

April 3, 2025

Trump and Allies Head to DC to Strategize on First 100 Days Achievements

February 28, 2025

Trump Addresses Judge’s Attempt to Halt Deportation Flights Amid Gang Violence Concerns

March 17, 2025

U.S. Defense Secretary Affirms Commitment to Allies Amid Chinese Pressure

May 31, 2025

Trump Impeachment Effort Stalls Amid Democratic Pressure

May 14, 2025

Subscribe to News

Get the latest sports news from NewsSite about world, sports and politics.

Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

News

  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Money Watch

Journos

  • Top Stories
  • Turkey Reports
  • Health
  • Tech
  • Sports
  • Entertainment

COMPANY

  • About Us
  • Get In Touch
  • Our Authors
  • Privacy Policy
  • Terms and Conditions
  • Accessibility

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

© 2025 The News Journos. Designed by The News Journos.

Type above and press Enter to search. Press Esc to cancel.

Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.